RT @peterbachmd: Intriguing @theNCI @NCIDrDougLowy @NEJM study showing lung cancer mortality rates falling since 2013 faster than incidence…
Intriguing @theNCI @NCIDrDougLowy @NEJM study showing lung cancer mortality rates falling since 2013 faster than incidence rates. Study title claims they observed the impact of improved treatments. I think that may be an overly strong conclusion. 1/n http
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
@ProfGenKanter Plausible, maybe. But article's title uses 'Effect' referring to treatment altering survival, but study neither measures nor observes treatment that I can see. To be somewhat blunt, this is a rsrch article not an oped. What am I missing? @NC
Advances in lung cancer treatment may have reduced lung cancer mortality. But, this paper does not show it. I am very surprised this paper was published with the title "The Effect of Advances in Lung-Cancer Treatment on Population Mortality". https://t.
RT @NCIDirector: The first-ever study of #LungCancer mortality by subtype exemplifies @theNCI’s ongoing commitment to #CancerResearch, #can…
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @harpreet_md: NCI Data from January recently published in NEJM highlights persistent ⬇️ in lung cancer mortality, largely due to novel t…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/5xeBHAJMNF
RT @nuria_dios: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/jLuiHO6kC3
RT @VanitaNoronha: Decrease in the population level mortality from NSCLC, primarily due to advances in therapy. @OncoAlert https://t.co/pSF…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
Encouraging trends : mortality (perhaps delayed) from NSCLC ↘️ faster than incidence in 🇺🇲, especially since 2013 : routine molecular screening and the use of targeted therapies 💊 have undeniably bent the curves ⤵️ @OncoAlert @NEJM https://t.co/49d9NaXWBo
Definitely a great "story" for sure, but to see a SEER analysis published in @NEJM... wow. And not even a reference to impact of oligomet #RT! 🤔And yes, last analytic year was 2016, but still! #lungcancer #lcsm #radonc https://t.co/9FNm7D0r1l
Importante questão levantada pelo @RicardoTerra12 em relação ao #câncer de pulmão, mas que se aplica a outras doenças pulmonares como #DPOC #Asma & #fibrosepulmonar: O sucesso na prevenção do #tabagismo 🚭 no 🇧🇷 não deveria ser estendido para o acess
Estudo mostra redução da mortalidade por câncer de pulmão nos EUA relacionada à diminuição de incidência mas a também tratamentos mais eficientes. Como seria no Brasil? The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https:
RT @VanitaNoronha: Decrease in the population level mortality from NSCLC, primarily due to advances in therapy. @OncoAlert https://t.co/pSF…
RT @harpreet_md: NCI Data from January recently published in NEJM highlights persistent ⬇️ in lung cancer mortality, largely due to novel t…
RT @harpreet_md: NCI Data from January recently published in NEJM highlights persistent ⬇️ in lung cancer mortality, largely due to novel t…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
Just published in @NEJM: Targeted therapies are improving survival for lung cancer. #GoBOLDLY @PhRMA https://t.co/wWxxUQdhH5
Lung-Cancer Survival is Improving https://t.co/4MnOPowuRF
RT @NCIDirector: The first-ever study of #LungCancer mortality by subtype exemplifies @theNCI’s ongoing commitment to #CancerResearch, #can…
RT @NCIDirector: The first-ever study of #LungCancer mortality by subtype exemplifies @theNCI’s ongoing commitment to #CancerResearch, #can…
RT @VivekSubbiah: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/e4z2WAzWsL
RT @VanitaNoronha: Decrease in the population level mortality from NSCLC, primarily due to advances in therapy. @OncoAlert https://t.co/pSF…
Death rates for #NSCLC (#lung #cancer) have fallen significantly in the U.S. in recent years, research indicates | NEJM https://t.co/Ag0QUyuDKp
RT @VanitaNoronha: Decrease in the population level mortality from NSCLC, primarily due to advances in therapy. @OncoAlert https://t.co/pSF…
RT @VanitaNoronha: Decrease in the population level mortality from NSCLC, primarily due to advances in therapy. @OncoAlert https://t.co/pSF…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @JamesBatesMD: Better lung cancer treatment --> lower mortality Also a SEER study got accepted to the NEJM https://t.co/jdbuknuNNy
NCI Data from January recently published in NEJM highlights persistent ⬇️ in lung cancer mortality, largely due to novel therapeutics. .@FDAOncology
Decrease in the population level mortality from NSCLC, primarily due to advances in therapy. @OncoAlert https://t.co/pSFFH9HlD1
RT @JamesBatesMD: Better lung cancer treatment --> lower mortality Also a SEER study got accepted to the NEJM https://t.co/jdbuknuNNy
That's impressive. Advances in lung cancer treatment leads to significant decrease in disease moratlity. Happy to ser this improvement but its still only a small step forward @NEJM #lcsm https://t.co/yyfOXDLTjP
Lung cancer mortality fell sharply in the United States in recent years, and this trend likely will continue. https://t.co/E4Jf0ZWDjK
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @NCIDirector: The first-ever study of #LungCancer mortality by subtype exemplifies @theNCI’s ongoing commitment to #CancerResearch, #can…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
RT @javierDcastro: Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadora…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/laMAuugEYw Reduction in incidence-based mortality and improvement in lung cancer-specific survival--there will be a further effect as we now have immunotherapy.
Las cifras lo confirman, desde 2016 se reduce la mortalidad por cáncer de pulmón, la introducción de terapias innovadoras y la detección precoz pueden ser la principal razón The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM htt
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
Seems good news, but this is mainly due to lower tobacco consumption in US. Look at statistics at https://t.co/gaPPrKqo28 trend started in 2000. @VPrasadMDMPH The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/3YBl
Here's the source 'Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, and survival after diagnosis improved substantially.' https://t.co/sUANqlLE8P
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/jLuiHO6kC3
RT @spkalantri: Oncogenic driver mutation | ALK or EGFR | TKIs | Improvement in NSC #lungcancer -specific survival. @NEJM tells us how pa…
RT @prat_aleix: @OncoAlert @NEJM -- Population-level mortality from NSCLC in the USA fell sharply from 2013 to 2016, and survival after dia…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
@OncoAlert @NEJM -- Population-level mortality from NSCLC in the USA fell sharply from 2013 to 2016, and survival after diagnosis improved substantially. 📉 reduction in incidence along `+ 📈approvals for and use of targeted therapies https://t.co/4qr5G0
RT @spkalantri: Oncogenic driver mutation | ALK or EGFR | TKIs | Improvement in NSC #lungcancer -specific survival. @NEJM tells us how pa…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @spkalantri: Oncogenic driver mutation | ALK or EGFR | TKIs | Improvement in NSC #lungcancer -specific survival. @NEJM tells us how pa…
This is why these are exciting times to be a thoracic oncologist!!!!
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @spkalantri: Oncogenic driver mutation | ALK or EGFR | TKIs | Improvement in NSC #lungcancer -specific survival. @NEJM tells us how pa…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
RT @spkalantri: Oncogenic driver mutation | ALK or EGFR | TKIs | Improvement in NSC #lungcancer -specific survival. @NEJM tells us how pa…
RT @weoncologists: Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. S…
Just out📣at @NEJM Population-level mortality from #NSCLC 🇺🇸fell from 2013-2016 w/survival after diagnosis improving. Study sees reduction in incidence & treatment🧪advances. #TargetedTherapies 🎯likely reason for mortality decrease #LungCancer #LCSM
Oncogenic driver mutation | ALK or EGFR | TKIs | Improvement in NSC #lungcancer -specific survival. @NEJM tells us how patients with lung cancer are living longer—and better—as molecular diagnosis and TKIs found their way in treatments. https://t.co/NU
RT @SageJulien: Exciting paper, except not as much for #SCLC "In contrast, mortality from SCLC declined almost entirely as a result of decl…
RT @VriesElisabeth: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/aTTzb0h4Lk
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/aTTzb0h4Lk
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
Encouraging that The Effect of Advances in Lung-Cancer Treatment on Population Mortality was seen across all races and ethnic groups in this study #lcsm | NEJM https://t.co/wFRHNIAjnq
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @LeXiuning: To all my peer thoracic oncology providers! Very proud! The Effect of Advances in Lung-Cancer Treatment on Population Mort…
RT @VivekSubbiah: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/e4z2WAzWsL
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/e4z2WAzWsL
To all my peer thoracic oncology providers! Very proud! The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/XHhgOdNpEi
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @twhitfill: Some exciting data on lung cancer this week in @NEJM suggests much higher survival since the beginning of the century. For…
The Effect of Advances in Lung-Cancer Treatment on Population Mortality: reduction in incidence along with treatment advances https://t.co/O2pNolikAb
Some exciting data on lung cancer this week in @NEJM suggests much higher survival since the beginning of the century. For example, survival improved from 26% to 35% among men with NSCLC that was diagnosed in 2001 to 2014 https://t.co/CJwfx5ts67 https:/
RT @SageJulien: Exciting paper, except not as much for #SCLC "In contrast, mortality from SCLC declined almost entirely as a result of decl…
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg
Encouraging findings suggesting we should keep pushing the envelope of personalized onco-therapeutics. #lcsm https://t.co/KYgQKYGnU4
Exciting paper, except not as much for #SCLC "In contrast, mortality from SCLC declined almost entirely as a result of declining incidence, with no improvement in survival" https://t.co/0r2QbqCu7y
RT @maryjofidlerMD: Exciting read highlighting big progress in Non small cell lung cancer. Still work to be done! @IASLC #LCSM https://t.co…
Great analysis. US population-level mortality trends in lung cancer, by disease subtype. Finding? A big drop in non-small cell cancer deaths. Likely explanation? (expensive) targeted drugs do what we hoped they'd do: help lots of ppl live longer. PROGRESS
Better lung cancer treatment --> lower mortality Also a SEER study got accepted to the NEJM https://t.co/jdbuknuNNy
This is the type of news that is often overlooked but shouldn't be.#lcsm
"...introduction of a new therapy that is not curative would contribute to a temporary decline in mortality, but mortality would return to the background level." - if there are no more advances. This is why lung cancer research matters. #lcsm
RT @n8pennell: The Effect of Advances in Lung-Cancer Treatment on Population Mortality | NEJM https://t.co/Ung4bm3ATg